Endometrial Abnormality in Women With Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy associated with infertility and metabolic disorder in women of reproductive age. Although the clinical and biochemical features are heterogeneous with individuals, the most widely accepted clinical characteristics of PCOS are oligo-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Reproductive Sciences 2012-07, Vol.19 (7), p.674-683
Hauptverfasser: Shang, Kewei, Jia, Xiao, Qiao, Jie, Kang, Jihong, Guan, Youfei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 683
container_issue 7
container_start_page 674
container_title Reproductive Sciences
container_volume 19
creator Shang, Kewei
Jia, Xiao
Qiao, Jie
Kang, Jihong
Guan, Youfei
description Polycystic ovary syndrome (PCOS) is the most common endocrinopathy associated with infertility and metabolic disorder in women of reproductive age. Although the clinical and biochemical features are heterogeneous with individuals, the most widely accepted clinical characteristics of PCOS are oligo- or anovulation combined with hyperandrogenism. With the higher rate of implantation failure after induction of ovulation or higher risk of spontaneous miscarriage after pregnancy, the reduced fertility is apparently attributed not only to anovulation but also to endometrial dysfunction in patients with PCOS. Here we review the features of the endometrial abnormalities in women with PCOS. The ability to improve the endometrial functions is of potential therapeutic targets to increase reproductive outcome of women with PCOS.
doi_str_mv 10.1177/1933719111430993
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1023534174</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1933719111430993</sage_id><sourcerecordid>1023534174</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-b65a35fb42d572cfb5384e6ad13f73a8f5972aaade737979f6485c0b74dd450c3</originalsourceid><addsrcrecordid>eNqNkEtLAzEUhYMotlb3rmQ2gpvRPCeTlZRSH1CooOJyyORRp8yjJjPC_HtTOlVwIW6ScM937r05AJwjeI0Q5zdIEMKRQAhRAoUgB2C8LcUcQ3a4fwd9BE68X0PIqMDpMRhhzAglmIzB7bzWTWVaV8gymuZ14ypZFm0fFXX0FoRwFu179NSUvep9W6ho-SldHz33tXZBPwVHVpbenA33BLzezV9mD_Fief84my5iRaFo4zxhkjCbU6wZx8rmjKTUJFIjYjmRqWWCYymlNpxwwYVNaMoUzDnVmjKoyARc7fpuXPPRGd9mVeGVKUtZm6bzGYKYhD8hTgMKd6hyjffO2GzjiiosHaBsG1v2O7ZguRi6d3ll9Ldhn1MALgdAeiVL62StCv_DJShFULDAoR3ng1SvjMvWTefqkMxfw-PBI1fmH_wXMrmPgQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1023534174</pqid></control><display><type>article</type><title>Endometrial Abnormality in Women With Polycystic Ovary Syndrome</title><source>SAGE Complete A-Z List</source><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Alma/SFX Local Collection</source><creator>Shang, Kewei ; Jia, Xiao ; Qiao, Jie ; Kang, Jihong ; Guan, Youfei</creator><creatorcontrib>Shang, Kewei ; Jia, Xiao ; Qiao, Jie ; Kang, Jihong ; Guan, Youfei</creatorcontrib><description>Polycystic ovary syndrome (PCOS) is the most common endocrinopathy associated with infertility and metabolic disorder in women of reproductive age. Although the clinical and biochemical features are heterogeneous with individuals, the most widely accepted clinical characteristics of PCOS are oligo- or anovulation combined with hyperandrogenism. With the higher rate of implantation failure after induction of ovulation or higher risk of spontaneous miscarriage after pregnancy, the reduced fertility is apparently attributed not only to anovulation but also to endometrial dysfunction in patients with PCOS. Here we review the features of the endometrial abnormalities in women with PCOS. The ability to improve the endometrial functions is of potential therapeutic targets to increase reproductive outcome of women with PCOS.</description><identifier>ISSN: 1933-7191</identifier><identifier>EISSN: 1933-7205</identifier><identifier>DOI: 10.1177/1933719111430993</identifier><identifier>PMID: 22534323</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Animals ; Biological and medical sciences ; Embryology ; Endometrial Neoplasms - etiology ; Endometrial Neoplasms - prevention &amp; control ; Endometrium - drug effects ; Endometrium - metabolism ; Endometrium - physiopathology ; Female ; Female genital diseases ; Gynecology. Andrology. Obstetrics ; Humans ; Infertility, Female - etiology ; Infertility, Female - prevention &amp; control ; Medical sciences ; Medicine &amp; Public Health ; Molecular Targeted Therapy ; Non tumoral diseases ; Obstetrics/Perinatology/Midwifery ; Polycystic Ovary Syndrome - drug therapy ; Polycystic Ovary Syndrome - metabolism ; Polycystic Ovary Syndrome - physiopathology ; Receptors, Steroid - agonists ; Receptors, Steroid - antagonists &amp; inhibitors ; Receptors, Steroid - metabolism ; Reproductive Medicine ; Review</subject><ispartof>Reproductive Sciences, 2012-07, Vol.19 (7), p.674-683</ispartof><rights>The Author(s) 2012</rights><rights>Society for Reproductive Investigation 2012</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-b65a35fb42d572cfb5384e6ad13f73a8f5972aaade737979f6485c0b74dd450c3</citedby><cites>FETCH-LOGICAL-c409t-b65a35fb42d572cfb5384e6ad13f73a8f5972aaade737979f6485c0b74dd450c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/1933719111430993$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/1933719111430993$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>313,314,776,780,788,21800,27901,27903,27904,41467,42536,43600,43601,51297</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26181095$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22534323$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shang, Kewei</creatorcontrib><creatorcontrib>Jia, Xiao</creatorcontrib><creatorcontrib>Qiao, Jie</creatorcontrib><creatorcontrib>Kang, Jihong</creatorcontrib><creatorcontrib>Guan, Youfei</creatorcontrib><title>Endometrial Abnormality in Women With Polycystic Ovary Syndrome</title><title>Reproductive Sciences</title><addtitle>Reprod. Sci</addtitle><addtitle>Reprod Sci</addtitle><description>Polycystic ovary syndrome (PCOS) is the most common endocrinopathy associated with infertility and metabolic disorder in women of reproductive age. Although the clinical and biochemical features are heterogeneous with individuals, the most widely accepted clinical characteristics of PCOS are oligo- or anovulation combined with hyperandrogenism. With the higher rate of implantation failure after induction of ovulation or higher risk of spontaneous miscarriage after pregnancy, the reduced fertility is apparently attributed not only to anovulation but also to endometrial dysfunction in patients with PCOS. Here we review the features of the endometrial abnormalities in women with PCOS. The ability to improve the endometrial functions is of potential therapeutic targets to increase reproductive outcome of women with PCOS.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Embryology</subject><subject>Endometrial Neoplasms - etiology</subject><subject>Endometrial Neoplasms - prevention &amp; control</subject><subject>Endometrium - drug effects</subject><subject>Endometrium - metabolism</subject><subject>Endometrium - physiopathology</subject><subject>Female</subject><subject>Female genital diseases</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Infertility, Female - etiology</subject><subject>Infertility, Female - prevention &amp; control</subject><subject>Medical sciences</subject><subject>Medicine &amp; Public Health</subject><subject>Molecular Targeted Therapy</subject><subject>Non tumoral diseases</subject><subject>Obstetrics/Perinatology/Midwifery</subject><subject>Polycystic Ovary Syndrome - drug therapy</subject><subject>Polycystic Ovary Syndrome - metabolism</subject><subject>Polycystic Ovary Syndrome - physiopathology</subject><subject>Receptors, Steroid - agonists</subject><subject>Receptors, Steroid - antagonists &amp; inhibitors</subject><subject>Receptors, Steroid - metabolism</subject><subject>Reproductive Medicine</subject><subject>Review</subject><issn>1933-7191</issn><issn>1933-7205</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkEtLAzEUhYMotlb3rmQ2gpvRPCeTlZRSH1CooOJyyORRp8yjJjPC_HtTOlVwIW6ScM937r05AJwjeI0Q5zdIEMKRQAhRAoUgB2C8LcUcQ3a4fwd9BE68X0PIqMDpMRhhzAglmIzB7bzWTWVaV8gymuZ14ypZFm0fFXX0FoRwFu179NSUvep9W6ho-SldHz33tXZBPwVHVpbenA33BLzezV9mD_Fief84my5iRaFo4zxhkjCbU6wZx8rmjKTUJFIjYjmRqWWCYymlNpxwwYVNaMoUzDnVmjKoyARc7fpuXPPRGd9mVeGVKUtZm6bzGYKYhD8hTgMKd6hyjffO2GzjiiosHaBsG1v2O7ZguRi6d3ll9Ldhn1MALgdAeiVL62StCv_DJShFULDAoR3ng1SvjMvWTefqkMxfw-PBI1fmH_wXMrmPgQ</recordid><startdate>20120701</startdate><enddate>20120701</enddate><creator>Shang, Kewei</creator><creator>Jia, Xiao</creator><creator>Qiao, Jie</creator><creator>Kang, Jihong</creator><creator>Guan, Youfei</creator><general>SAGE Publications</general><general>Springer International Publishing</general><general>Sage Publications</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120701</creationdate><title>Endometrial Abnormality in Women With Polycystic Ovary Syndrome</title><author>Shang, Kewei ; Jia, Xiao ; Qiao, Jie ; Kang, Jihong ; Guan, Youfei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-b65a35fb42d572cfb5384e6ad13f73a8f5972aaade737979f6485c0b74dd450c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Embryology</topic><topic>Endometrial Neoplasms - etiology</topic><topic>Endometrial Neoplasms - prevention &amp; control</topic><topic>Endometrium - drug effects</topic><topic>Endometrium - metabolism</topic><topic>Endometrium - physiopathology</topic><topic>Female</topic><topic>Female genital diseases</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Infertility, Female - etiology</topic><topic>Infertility, Female - prevention &amp; control</topic><topic>Medical sciences</topic><topic>Medicine &amp; Public Health</topic><topic>Molecular Targeted Therapy</topic><topic>Non tumoral diseases</topic><topic>Obstetrics/Perinatology/Midwifery</topic><topic>Polycystic Ovary Syndrome - drug therapy</topic><topic>Polycystic Ovary Syndrome - metabolism</topic><topic>Polycystic Ovary Syndrome - physiopathology</topic><topic>Receptors, Steroid - agonists</topic><topic>Receptors, Steroid - antagonists &amp; inhibitors</topic><topic>Receptors, Steroid - metabolism</topic><topic>Reproductive Medicine</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shang, Kewei</creatorcontrib><creatorcontrib>Jia, Xiao</creatorcontrib><creatorcontrib>Qiao, Jie</creatorcontrib><creatorcontrib>Kang, Jihong</creatorcontrib><creatorcontrib>Guan, Youfei</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Reproductive Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shang, Kewei</au><au>Jia, Xiao</au><au>Qiao, Jie</au><au>Kang, Jihong</au><au>Guan, Youfei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Endometrial Abnormality in Women With Polycystic Ovary Syndrome</atitle><jtitle>Reproductive Sciences</jtitle><stitle>Reprod. Sci</stitle><addtitle>Reprod Sci</addtitle><date>2012-07-01</date><risdate>2012</risdate><volume>19</volume><issue>7</issue><spage>674</spage><epage>683</epage><pages>674-683</pages><issn>1933-7191</issn><eissn>1933-7205</eissn><abstract>Polycystic ovary syndrome (PCOS) is the most common endocrinopathy associated with infertility and metabolic disorder in women of reproductive age. Although the clinical and biochemical features are heterogeneous with individuals, the most widely accepted clinical characteristics of PCOS are oligo- or anovulation combined with hyperandrogenism. With the higher rate of implantation failure after induction of ovulation or higher risk of spontaneous miscarriage after pregnancy, the reduced fertility is apparently attributed not only to anovulation but also to endometrial dysfunction in patients with PCOS. Here we review the features of the endometrial abnormalities in women with PCOS. The ability to improve the endometrial functions is of potential therapeutic targets to increase reproductive outcome of women with PCOS.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>22534323</pmid><doi>10.1177/1933719111430993</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1933-7191
ispartof Reproductive Sciences, 2012-07, Vol.19 (7), p.674-683
issn 1933-7191
1933-7205
language eng
recordid cdi_proquest_miscellaneous_1023534174
source SAGE Complete A-Z List; MEDLINE; Springer Nature - Complete Springer Journals; Alma/SFX Local Collection
subjects Animals
Biological and medical sciences
Embryology
Endometrial Neoplasms - etiology
Endometrial Neoplasms - prevention & control
Endometrium - drug effects
Endometrium - metabolism
Endometrium - physiopathology
Female
Female genital diseases
Gynecology. Andrology. Obstetrics
Humans
Infertility, Female - etiology
Infertility, Female - prevention & control
Medical sciences
Medicine & Public Health
Molecular Targeted Therapy
Non tumoral diseases
Obstetrics/Perinatology/Midwifery
Polycystic Ovary Syndrome - drug therapy
Polycystic Ovary Syndrome - metabolism
Polycystic Ovary Syndrome - physiopathology
Receptors, Steroid - agonists
Receptors, Steroid - antagonists & inhibitors
Receptors, Steroid - metabolism
Reproductive Medicine
Review
title Endometrial Abnormality in Women With Polycystic Ovary Syndrome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T13%3A11%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Endometrial%20Abnormality%20in%20Women%20With%20Polycystic%20Ovary%20Syndrome&rft.jtitle=Reproductive%20Sciences&rft.au=Shang,%20Kewei&rft.date=2012-07-01&rft.volume=19&rft.issue=7&rft.spage=674&rft.epage=683&rft.pages=674-683&rft.issn=1933-7191&rft.eissn=1933-7205&rft_id=info:doi/10.1177/1933719111430993&rft_dat=%3Cproquest_cross%3E1023534174%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1023534174&rft_id=info:pmid/22534323&rft_sage_id=10.1177_1933719111430993&rfr_iscdi=true